US approves Pfizer’s maternal RSV vaccine to protect infants
The approval allows the vaccine to be given to women 32 to 36 weeks into a pregnancy to prevent lower ...
The approval allows the vaccine to be given to women 32 to 36 weeks into a pregnancy to prevent lower ...
All content is Copyrighted © 2024 The Premium Times, Nigeria
All content is Copyrighted © 2024 The Premium Times, Nigeria